Skip to content

Evaluating the Effects of a Computerized Training Program Coupled With Cognitive Behavioral Therapy (CBT) for OCD.

Personalized Computerized Inhibitory Control Training for OCD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03855943
Enrollment
100
Registered
2019-02-27
Start date
2019-04-11
Completion date
2024-06-30
Last updated
2022-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Brief summary

This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

Detailed description

This study will evaluate the effectiveness of a computerized training program (called Personalized Computerized Inhibitory Training, or PCIT) coupled with cognitive behavioral therapies (CBT) consisting of Exposures and Response Prevention in treating obsessive compulsive disorder (OCD) in patients who previously underwent CBT, but still have residual symptoms.

Interventions

Training with a personalized computerized inhibitory training program

BEHAVIORALCBT

Cognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy

Sponsors

Hebrew University of Jerusalem
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Principal diagnosis of OCD (assessed by SCID). * Clinically significant OCD symptoms (Y-BOCS score of at least 14). * Allowed to be on medications if they have been on a stable dose for at least 12 weeks prior to the study and will remain on a stable dose during this study. * Have access to a computer or laptop.

Exclusion criteria

* Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID). * Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system. * Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry. * Patients with a history of more than 8 hours of therapist-assisted ERP for OCD in the past 6 months, * Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded). * Active suicidality warranting immediate clinical care.

Design outcomes

Primary

MeasureTime frameDescription
Obsessive-compulsive symptoms measured after 3 weeks of treatment3 weeksMeasured by Yale-Brown Obsessive Compulsive Scale (YBOCS), considered the gold standard assessment tool. Y-BOCS comprises a Symptom Checklist and Severity Scale to consecutively rate obsessions and compulsions. The Checklist includes 54 common obsessions and compulsive behaviors, which are grouped according to thematic content. Symptoms that are endorsed over the past week are then globally rated by the clinician using a five-point scale ranging from 0 (none) to 4 (extreme) across five dimensions: (1) time/frequency, (2) interference, (3) distress, (4) resistance, and (5) degree of control. Obsessive and compulsive symptom severity are rated separately (scores range from 0 to 25) with these scores summed to create a total OCD severity score (range, 0-50). Symptom severity scores: mild symptoms (0-13), moderate symptoms (14-25), moderate-severe symptoms (26-34), and severe symptoms (35-40).26

Countries

Israel

Contacts

Primary ContactNoa Tauber, MA
noa.tauber@mail.huji.ac.il559714264

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026